- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 89Zr-pertuzumab
Total 569 results
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
The University of Hong Kong-Shenzhen HospitalTianjin Happy Life Technology Co., Ltd.Not yet recruitingFeasibility | Safety | Targeted Molecular Therapy | Effectiveness
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Hoffmann-La RocheCompleted
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Fudan UniversityActive, not recruiting
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingKidney Cancer | Clear Cell Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States
-
Robert Redner, MDPfizerActive, not recruiting
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedInflammatory Breast CarcinomaUnited States
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
Nantes University HospitalCompleted
-
University of Illinois at ChicagoRecruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Sweden
-
University of UlmCompletedLeukemia, Myeloid, AcuteGermany, Austria
-
Roswell Park Cancer InstitutePfizerActive, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Hoffmann-La RocheCompleted
-
The Greater Poland Cancer CentreActive, not recruiting
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Samsung Medical CenterUnknownAcute Myeloid LeukemiaKorea, Republic of
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Stage III Colon Cancer | Stage III Rectal Cancer | Adenocarcinoma of the ColonUnited States
-
University of Maryland, BaltimoreHematologics, IncRecruitingAcute Myeloid Leukemia Recurrent | Acute Myeloid Leukemia, Adult | Acute Myeloid Leukemia, Relapsed, AdultUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada, Australia
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Hoffmann-La RocheCompletedGastric CancerAustria, Belgium, Brazil, Canada, China, Croatia, Finland, Hungary, Italy, Korea, Republic of, Mexico, Poland, Spain, Turkey, United States, Kazakhstan, Peru, Russian Federation, Switzerland, Taiwan, Thailand, Germany, Japan, Malaysia, ... and more
-
Zhujiang HospitalRecruitingProstate Cancer With ≤10 Bone MetastasesChina
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast NeoplasmsItaly, Netherlands, Belgium, United Kingdom, Argentina, Austria, Brazil, China, Ecuador, Estonia, Finland, France, Germany, Greece, Mexico, Peru, Poland, Portugal, Slovenia, Spain, United Arab Emirates, Canada, Hungary, Israel, Sweden, Tu... and more
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompleted